Name | Number of supported studies | Average coverage | |
---|---|---|---|
type I pneumocyte | 12 studies | 47% ± 19% | |
type II pneumocyte | 12 studies | 79% ± 20% | |
conventional dendritic cell | 5 studies | 34% ± 11% | |
dendritic cell | 4 studies | 25% ± 10% | |
B cell | 4 studies | 20% ± 2% | |
plasmacytoid dendritic cell | 4 studies | 46% ± 25% | |
epithelial cell of proximal tubule | 3 studies | 20% ± 3% | |
epithelial cell | 3 studies | 38% ± 14% | |
memory B cell | 3 studies | 24% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 5 studies | 28% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 34188.35 | 578 / 578 | 74% | 353.84 | 854 / 1155 |
kidney | 100% | 4935.25 | 89 / 89 | 64% | 20.65 | 577 / 901 |
thymus | 100% | 211.23 | 653 / 653 | 37% | 8.02 | 225 / 605 |
spleen | 100% | 120.59 | 241 / 241 | 0% | 0 | 0 / 0 |
uterus | 99% | 80.39 | 168 / 170 | 1% | 2.29 | 5 / 459 |
pancreas | 98% | 71.07 | 323 / 328 | 0% | 0 | 0 / 178 |
ovary | 96% | 151.93 | 173 / 180 | 1% | 0.07 | 6 / 430 |
bladder | 90% | 50.81 | 19 / 21 | 7% | 40.40 | 35 / 504 |
intestine | 95% | 89.53 | 917 / 966 | 1% | 0.20 | 6 / 527 |
prostate | 96% | 132.36 | 234 / 245 | 0% | 0.02 | 2 / 502 |
brain | 93% | 48.69 | 2466 / 2642 | 0% | 0.07 | 2 / 705 |
liver | 93% | 71.71 | 210 / 226 | 0% | 0 | 0 / 406 |
breast | 91% | 73.90 | 419 / 459 | 1% | 0.06 | 9 / 1118 |
skin | 89% | 83.24 | 1611 / 1809 | 2% | 0.95 | 9 / 472 |
stomach | 90% | 54.98 | 322 / 359 | 1% | 0.08 | 3 / 286 |
esophagus | 83% | 42.64 | 1202 / 1445 | 2% | 0.33 | 3 / 183 |
adipose | 81% | 45.34 | 979 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 78% | 159.11 | 723 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 72% | 34.50 | 964 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 72% | 27.25 | 186 / 258 | 0% | 0 | 0 / 230 |
heart | 61% | 24.58 | 528 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 48% | 5.73 | 14 / 29 |
muscle | 21% | 7.70 | 170 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.07 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006508 | Biological process | proteolysis |
GO_0043129 | Biological process | surfactant homeostasis |
GO_0033619 | Biological process | membrane protein proteolysis |
GO_0097486 | Cellular component | multivesicular body lumen |
GO_0005615 | Cellular component | extracellular space |
GO_0097208 | Cellular component | alveolar lamellar body |
GO_0005764 | Cellular component | lysosome |
GO_0070062 | Cellular component | extracellular exosome |
GO_0004190 | Molecular function | aspartic-type endopeptidase activity |
GO_0008233 | Molecular function | peptidase activity |
GO_0004175 | Molecular function | endopeptidase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NAPSA |
Protein name | Napsin A aspartic peptidase Napsin-A (EC 3.4.23.-) (Aspartyl protease 4) (ASP4) (Asp 4) (Napsin-1) (TA01/TA02) |
Synonyms | NAPA NAP1 |
Description | FUNCTION: May be involved in processing of pneumocyte surfactant precursors. |
Accessions | ENST00000599233.1 ENST00000253719.7 ENST00000598915.6 O96009 A0A0B4J2A8 M0QXC5 |